Has Michael Levine, MD received payments from drug or device companies?

Yes. Drug and device makers reported $628,517 in general payments to Michael Levine, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Levine, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Levine, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Levine, MD

Orthopaedic Surgery · Monroeville, PANPI 1447232202

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $612,162 of the $628,517 with a category attached, or 97.4%. Encore Medical, LP accounts for 97.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $132,680 and has fallen 99.3% since, to $872 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$628,517in general payments, 2019–2025

Across 104 payments — averaging $6043.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Encore Medical, LP$615K
Exactech, Inc.$4K
Spineguard, Inc.$2K
Zimmer Biomet$2K
Johnson & Johnson$1K
Innovation Technologies Inc$1K
plus $3K from 10 others

$2,375in research payments, 2019–2025

Across 6 payments — averaging $395.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Conformis, Inc.$2K

What the payments were for

Royalty or licence$612,16297%
Consulting fees$5,2501%
Travel & lodging$4,5741%
Food & beverage$6,5311%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Encore Medical, LP	26	$615,289
Exactech, Inc.	8	$4,334
Spineguard, Inc.	4	$2,250
Zimmer Biomet	13	$1,507
Johnson & Johnson	11	$1,243
Innovation Technologies Inc	12	$1,142
Pacira Pharmaceuticals Incorporated	7	$1,132
Next Science LLC	8	$477
Stryker	4	$429
Amgen	4	$382
Vericel Corporation	1	$125
Heron Therapeutics, Inc.	1	$53
Pacira Therapeutics, Inc.	1	$50
Bioventus LLC	1	$47
Medical Device Business Services, Inc.	2	$43
Ferring Pharmaceuticals Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO SURGICAL$342,677
DJO Surgical TaperFill Hip System$272,612
EQUINOXE$4,334
DJO Surgical FMP Acetabular System$3,000
Iovera$1,056
Irrisept$899
ROSA-Knee$552
ATTUNE$410
Persona$407
ROSA$400
MAKO$276
SurgX$253
Xperience$253
BlastX$253
Comprehensive Shoulder System$127
MACI$125
mymobility Platform$104

How this compares

$628,517 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$83,408

Medicare patients

226

Services billed

2,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Naproxen	120	$794
Diclofenac Sodium	22	$251
Methylprednisolone	30	$173
Cephalexin	14	$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Monroeville

William HozackBensalem$10.6M
Jess LonnerBryn Mawr$7.8M
Gerald WilliamsBryn Mawr$6.8M
Mark LazarusBensalem$6.4M
John FenlinPhiladelphia$5.9M
Peter SharkeyKing Of Prussia$5.7M
Alexander VaccaroPhiladelphia$4.5M
Selene ParekhBensalem$4.5M
Joseph AbboudPhiladelphia$3.9M
Jonathan GarinoMalvern$3.8M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →